dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· January 26, 2026

UPS (UPS) Q1 2025 Earnings Call Transcript

View original at nasdaq.com
UPS (UPS) Q1 2025 Earnings Call Transcript Image source: The Motley Fool. DATE Tuesday, April 29, 2025 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Carol TomeChief Financial Officer — Brian DykesPresident, U.S…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The world hasn't faced such enormous potential impacts to trade in more than 100 years

    80% confidence
  • UPS has built in chaos costs to manage volume and maintain service during Q2 facility closures, impacting margin improvement

    80% confidence
  • The only certainty is that UPS doesn't know which scenario will play out for full-year outlook

    80% confidence
  • China-to-rest-of-world volume expected up 40% in Q2 2025

    80% confidence
  • Supply Chain Solutions revenue expected down approximately $500M in Q2 2025 due to Coyote divestiture

    80% confidence
  • International revenue expected down approximately 2% in Q2 2025

    80% confidence
  • Uncertainty surrounding global trade policies and other matters led to a drop in consumer confidence and muted demand in February-March 2025

    80% confidence
  • U.S. Domestic operating margin expected up approximately 30 bps to approximately 9.3% in Q2 2025

    80% confidence
  • Many UPS SMB customers are 100% single-sourced from China, causing uncertainty due to 145% tariff announcement

    80% confidence
  • UPS ultimate target is 400 facilities partially or fully automated with 200 facilities closed

    80% confidence
  • 95% of small package customers expect to maintain current shipping models despite tariffs

    80% confidence
  • U.S. ADV expected down approximately 9% in Q2 2025

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Un éditeur vérifie les conflits entre sources avant de les publier ici.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com

Données de travail, pas l’article final. Voici ce que notre IA a lu et extrait des documents sources jusqu’ici. Notre méthode

UPS (UPS) Q1 2025 Earnings Call Transcript: Source | Via News | fr.via.news